You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin-Ineligible

Showing 1 - 25 of 2,831
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscle-Invasive Bladder Carcinoma, Bladder Cancer Trial in Tampa (CG0070, Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Bladder Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Metastatic Malignancy
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Bladder Cancer Trial in Fairway, Kansas City (Ascorbic Acid)

Active, not recruiting
  • Bladder Cancer
  • Ascorbic Acid
  • Fairway, Kansas
  • +2 more
Sep 21, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

Completed
Has Results
  • Bladder Cancer
  • Tampa, Florida
  • +7 more
Nov 4, 2022

Urothelial Carcinoma Bladder Trial in Houston (drug, radiation, procedure)

Recruiting
  • Urothelial Carcinoma Bladder
  • Houston, Texas
    Houston Methodist Hospital
Feb 15, 2022

Cancer of Head and Neck Trial in Hannover (Pembrolizumab Injection, Methotrexate Injectable Solution)

Active, not recruiting
  • Cancer of Head and Neck
  • Pembrolizumab Injection
  • Methotrexate Injectable Solution
  • Hannover, Germany
    Medizinsche Hochschule Hannover
Dec 14, 2021

Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

Withdrawn
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • (no location specified)
Aug 8, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Zhengzhou (Toripalimab, Gemcitabine)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 24, 2021

Urothelial Carcinoma, Bladder Cancer, Transitional Cell Carcinoma Trial in United States (nab-paclitaxel, Gemcitabine)

Terminated
Has Results
  • Urothelial Carcinoma
  • +2 more
  • Fort Myers, Florida
  • +4 more
Dec 15, 2021

Urothelial Carcinoma Trial in United States (Carboplatin, Gemcitabine, Atezolizumab)

Active, not recruiting
  • Urothelial Carcinoma
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 17, 2022

Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Terminated
  • Urothelial Carcinoma
  • Phoenix, Arizona
  • +7 more
Dec 15, 2022

Metastatic Urothelial Cancer Trial in United States (Nivolumab, Gemcitabine, Carboplatin)

Active, not recruiting
  • Metastatic Urothelial Cancer
  • Baltimore, Maryland
  • +5 more
Sep 7, 2021

Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

Recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
  • +11 more
Dec 1, 2022

Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

Recruiting
  • Bladder Carcinoma
  • +7 more
  • Atezolizumab
  • +5 more
  • Toronto, Ontario, Canada
    University Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022

Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023

Bladder Cancer, Urothelial Carcinoma Trial in Porto Alegre (Olaparib, Durvalumab)

Terminated
  • Bladder Cancer
  • Urothelial Carcinoma
  • Porto Alegre, Brazil
    Centro de Pesquisa em Oncologia
Jun 14, 2021

Bladder Cancer Trial in United States (Nivolumab, Ipilimumab, Radical cystectomy)

Recruiting
  • Bladder Cancer
  • Basking Ridge, New Jersey
  • +6 more
Feb 1, 2022

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (biological, drug, radiation)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Nivolumab
  • +3 more
  • Anniston, Alabama
  • +54 more
Aug 5, 2021

Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)

Completed
  • Urinary Bladder Neoplasm
  • Neoplasm Metastasis
  • Bempegaldesleukin
  • Nivolumab
  • San Francisco, California
  • +69 more
Jul 22, 2022